Taurolidine promotes cell apoptosis by enhancing GRIM‑19 expression in liver cancer
Synergistic apoptotic effects of taurolidine and TRAIL on squamous carcinoma cells of the esophagus
Piperlongumine reverses doxorubicin resistance through the PI3K/Akt signaling pathway in K562/A02 human leukemia cells
Potent antitumor agent proteasome inhibitors: a novel trigger for Bcl2 phosphorylation to induce apoptosis.
Effects of TRAIL and taurolidine on apoptosis and proliferation in human rhabdomyosarcoma, leiomyosarcoma and epithelioid cell sarcoma